NASHVILLE, Tenn., July 15, 2025 – Onsite Women’s Health, the nation’s largest provider of in-office breast health and imaging services, today announced that Kristy Rutherford has been appointed as Chief Financial Officer, effective immediately. Rutherford succeeds Michael McCooey and brings over 25 years of financial leadership experience in healthcare.
In this role, Rutherford will be responsible for Onsite’s company-wide financial operations that span more than 150 locations in 26 states. Through its collaborative care model, Onsite partners with OBGYN and primary care practices to enable healthcare providers to offer comprehensive breast health and imaging services – anchored by a strong 3D screening mammography platform complete with AI for cancer detection – within their practices.
“We are thrilled to welcome Kristy to Onsite Women’s Health,” said Jillian Wright, chief executive officer at Onsite Women’s Health. “She is a mission-driven leader who brings a strong focus on operational efficiency, a collaborative spirit and a people-first approach—qualities that make her an exceptional addition to our team.”
Previously, Rutherford served as Chief Financial Officer at Marquee Dental Partners, a private equity-backed DSO of similar size and complexity to Onsite. Prior roles at AMSURG and Envision Healthcare further demonstrate her leadership in treasury operations, SEC reporting and financial strategy across multi-state, multi-site healthcare environments.
“I’m thrilled to join Onsite Women’s Health and support its focus on improving access to breast health and imaging services,” said Kristy Rutherford. “I look forward to helping advance the organization’s growth and continued impact on women’s healthcare.”
About Onsite Women’s Health
In partnership with forward-thinking providers across the country, Onsite Women’s Health offers comprehensive in-office breast health and imaging services – anchored by a strong 3D screening mammography platform complete with AI for cancer detection. Committed to saving more women’s lives through earlier diagnosis, Onsite is driving measurable improvements in breast cancer screening compliance and detection rates by expanding convenient access to mammography, working with breast-specialized radiologists and utilizing the most advanced equipment and AI-powered technology available. Onsite’s model enhances patient satisfaction, strengthens breast health services, and creates new revenue opportunities for practice partners. Since its founding in 2008, Onsite has performed more than two million exams across 26 states.
